{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T22:52:02Z","timestamp":1772491922447,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"German cancer consortium (DKTK), partner site Dresden"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13063-017-2346-0","type":"journal-article","created":{"date-parts":[[2017,12,20]],"date-time":"2017-12-20T06:43:35Z","timestamp":1513752215000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["PORTAF \u2013 postoperative radiotherapy of non-small cell lung cancer: accelerated versus conventional fractionation \u2013 study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9576-9469","authenticated-orcid":false,"given":"R.","family":"B\u00fctof","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"L\u00f6ck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. G. C.","family":"Troost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Appold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Krause","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,20]]},"reference":[{"key":"2346_CR1","doi-asserted-by":"crossref","first-page":"29S","DOI":"10.1378\/chest.07-1347","volume":"132","author":"AJ Alberg","year":"2007","unstructured":"Alberg AJ, Ford JG, Samet JM. Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132:29S\u201355.","journal-title":"Chest."},{"key":"2346_CR2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-0030-1255961","volume":"65","author":"G Goeckenjan","year":"2011","unstructured":"Goeckenjan G, Sitter H, Thomas M, et al. Prevention, diagnosis, therapy, and follow-up of lung cancer: interdisciplinary guideline of the German Respiratory Society and the German Cancer Society. Pneumologie. 2011;65:39\u201359.","journal-title":"Pneumologie."},{"key":"2346_CR3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0140-6736(98)06341-7","volume":"352","author":"Group PM-aT","year":"1998","unstructured":"Group PM-aT. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet. 1998;352:257\u201363.","journal-title":"Lancet"},{"key":"2346_CR4","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1634\/theoncologist.2010-0150","volume":"16","author":"C Pechoux Le","year":"2011","unstructured":"Le Pechoux C. Role of postoperative radiotherapy in resected non-small cell lung cancer: a reassessment based on new data. Oncologist. 2011;16:672\u201381.","journal-title":"Oncologist."},{"key":"2346_CR5","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1634\/theoncologist.2010-0343","volume":"16","author":"H Dai","year":"2011","unstructured":"Dai H, Hui Z, Ji W, et al. Postoperative radiotherapy for resected pathological stage IIIA-N2 non-small cell lung cancer: a retrospective study of 221 cases from a single institution. Oncologist. 2011;16:641\u201350.","journal-title":"Oncologist."},{"key":"2346_CR6","first-page":"1164","volume":"12","author":"F Du","year":"2009","unstructured":"Du F, Yuan Z, Wang J, et al. The role of postoperative radiotherapy on stage N2 non-small cell lung cancer. Zhongguo Fei Ai Za Zhi. 2009;12:1164\u20138.","journal-title":"Zhongguo Fei Ai Za Zhi."},{"key":"2346_CR7","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1200\/JCO.2005.04.6110","volume":"24","author":"BE Lally","year":"2006","unstructured":"Lally BE, Zelterman D, Colasanto JM, Haffty BG, Detterbeck FC, Wilson LD. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database. J Clin Oncol. 2006;24:2998\u20133006.","journal-title":"J Clin Oncol."},{"key":"2346_CR8","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.cllc.2012.05.007","volume":"14","author":"C Mantovani","year":"2013","unstructured":"Mantovani C, Giaj Levra N, Filippi AR, et al. Postoperative radiotherapy for patients with completely resected pathologic N2 non-small-cell lung cancer: a retrospective analysis. Clin Lung Cancer. 2013;14:194\u20139.","journal-title":"Clin Lung Cancer."},{"key":"2346_CR9","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa031644","volume":"350","author":"R Arriagada","year":"2004","unstructured":"Arriagada R, Bergman B, Dunant A, Le Chevalier T, Pignon JP, Vansteenkiste J. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med. 2004;350:351\u201360.","journal-title":"N Engl J Med."},{"key":"2346_CR10","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(10)60059-1","volume":"375","author":"R Arriagada","year":"2010","unstructured":"Arriagada R, Auperin A, Burdett S, et al. Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data. Lancet. 2010;375:1267\u201377.","journal-title":"Lancet."},{"issue":"3","key":"2346_CR11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.radonc.2013.03.007","volume":"106","author":"R B\u00fctof","year":"2013","unstructured":"B\u00fctof R, Baumann M. Time in radiation oncology - keep it short! Radiother Oncol. 2013;106(3):271\u20135.","journal-title":"Radiother Oncol."},{"key":"2346_CR12","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0360-3016(97)00380-5","volume":"39","author":"F Wurschmidt","year":"1997","unstructured":"Wurschmidt F, Bunemann H, Ehnert M, Heilmann HP. Is the time interval between surgery and radiotherapy important in operable nonsmall cell lung cancer? A retrospective analysis of 340 cases. Int J Radiat Oncol Biol Phys. 1997;39:553\u20139.","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"3","key":"2346_CR13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00066-013-0501-4","volume":"190","author":"R B\u00fctof","year":"2014","unstructured":"B\u00fctof R, Kirchner K, Appold S, et al. Potential clinical predictors of outcome after postoperative radiotherapy of non-small cell lung cancer. Strahlenther Onkol. 2014;190(3):263\u20139.","journal-title":"Strahlenther Onkol"},{"key":"2346_CR14","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1200\/JCO.2012.41.6677","volume":"30","author":"A Mauguen","year":"2012","unstructured":"Mauguen A, Le Pechoux C, Saunders MI, et al. Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis. J Clin Oncol. 2012;30:2788\u201397.","journal-title":"J Clin Oncol."},{"key":"2346_CR15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0167-8140(99)00093-6","volume":"52","author":"D Ball","year":"1999","unstructured":"Ball D, Bishop J, Smith J, et al. A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial. Radiother Oncol. 1999;52:129\u201336.","journal-title":"Radiother Oncol."},{"key":"2346_CR16","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.radonc.2011.06.031","volume":"100","author":"M Baumann","year":"2011","unstructured":"Baumann M, Herrmann T, Koch R, et al. Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC). Radiother Oncol. 2011;100:76\u201385.","journal-title":"Radiother Oncol."},{"key":"2346_CR17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0140-6736(97)06305-8","volume":"350","author":"M Saunders","year":"1997","unstructured":"Saunders M, Dische S, Barrett A, Harvey A, Gibson D, Parmar M. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee. Lancet. 1997;350:161\u20135.","journal-title":"Lancet."},{"key":"2346_CR18","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/jnci\/87.3.198","volume":"87","author":"WT Sause","year":"1995","unstructured":"Sause WT, Scott C, Taylor S, et al. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer. J Natl Cancer Inst. 1995;87:198\u2013205.","journal-title":"J Natl Cancer Inst."},{"key":"2346_CR19","doi-asserted-by":"publisher","unstructured":"Skripcak T, Just U, Simon M, et al. Towards distributed conduction of large scale studies in radiation therapy and oncology: open source system integration approach. IEEE J Biomed Health Inform 2016; epub. doi:\n10.1109\/JBHI.2015.2450833\n\n.","DOI":"10.1109\/JBHI.2015.2450833"},{"key":"2346_CR20","unstructured":"Chow S, Shao J, Wang H. Sample size calculations in clinical research. 2nd ed. Boca Raton: Chapman & Hall\/CRC Biostatistics Series; 2008. p. 177"},{"issue":"3","key":"2346_CR21","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.radonc.2016.02.011","volume":"118","author":"I Walraven","year":"2016","unstructured":"Walraven I, van den Heuvel M, van Diessen J, et al. Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab. Radiother Oncol. 2016;118(3):442\u20136.","journal-title":"Radiother Oncol"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-017-2346-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,20]],"date-time":"2017-12-20T06:44:07Z","timestamp":1513752247000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-017-2346-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2346"],"URL":"https:\/\/doi.org\/10.1186\/s13063-017-2346-0","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"608"}}